Sophia Randolph, Chief Medical Officer at ALX ONCOLOGY HOLDINGS INC (ALXO), sold 14,674 shares at $74.35 ($1.1M) on 2021-03-10, disclosed to the SEC on 2021-03-12.
Open-market sale of $1.1M ALXO by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $73.38 | 1,297 | $95K | 8.7% |
| 2 | $73.38 | 1,297 | $95K | 8.7% |
| 3 | $74.35 | 4,844 | $360K | 33.0% |
| 4 | $74.35 | 4,844 | $360K | 33.0% |
| 5 | $75.20 | 1,146 | $86K | 7.9% |
| 6 | $75.20 | 1,146 |
| $86K |
| 7.9% |
| 7 | $76.69 | 100 | $8K | 0.7% |
| Total | $74.33 avg | 14,674 | $1.1M | 100% |
| Filing → |
| ALXO | SELL | 2024-05-15 | $353K | — | Filing → |
| ALXO | SELL | 2024-01-03 | $47K | — | Filing → |
| ALXO | SELL | 2023-07-05 | $12K | — | Filing → |